Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Jansen, MAM; Korevaar, JC; Dekker, FW; Jager, KJ; Boeschoten, EW; Krediet, RT; Apperloo, AJ; Barendrecht, JNM; Birnie, RJ; Boekhout, M; Boer, WH; Buller, HR; de Charro, FT; Doorenbos, CJ; Fagel, WJ; Feith, GW; Franssen, CFM; Frenken, LAM; Geerlings, W; Gerlag, PGG; Gorgels, JPMC; Grave, W; Huisman, RM; Jie, K; Koning-Mulder, WAH; Koolen, MI; Hovinga, TKK; Lavrijssen, ATJ; Mulder, AW; Parlevliet, KJ; Rosman, JB; Schonck, MJM; Schuurmans, MMJ; Stevens, P; Tijssen, JGP; Valentijn, RM; van Bommel, EFH; van Dorp, WT; van Es, A; van Geelen, JACA; van Saase, JLCM; Vastenburg, G; Verburgh, CA; Verhagen, CE; Verstappen, VMC; Vincent, HH; Vos, P
   The relationship between Kt/V-urea and nPNA in anuric peritoneal dialysis patients: A comparison with predialysis patients
   PERITONEAL DIALYSIS INTERNATIONAL
   
   M.A.M. Jansen et al., "The relationship between Kt/V-urea and nPNA in anuric peritoneal dialysis patients: A comparison with predialysis patients", PERIT DIA I, 21(5), 2001, pp. 509-515
2. Tulevski, II; Hirsch, A; Sanson, BJ; Romkes, H; van der Wall, EE; van Veldhuisen, DJ; Buller, HR; Mulder, BJM
   Increased brain natriuretic peptide as a marker for right ventricular dysfunction in acute pulmonary embolism
   THROMBOSIS AND HAEMOSTASIS
   
   I.I. Tulevski et al., "Increased brain natriuretic peptide as a marker for right ventricular dysfunction in acute pulmonary embolism", THROMB HAEM, 86(5), 2001, pp. 1193-1196
3. Mac Gillavry, MR; Buller, HR; Brandjes, DPM
   The usefulness of compression ultrasonography of the lower limbs in patients with a clinical suspicion of pulmonary embolism
   THROMBOSIS AND HAEMOSTASIS
   
   M.R. Mac Gillavry et al., "The usefulness of compression ultrasonography of the lower limbs in patients with a clinical suspicion of pulmonary embolism", THROMB HAEM, 86(2), 2001, pp. 726-726
4. Mac Gillavry, MR; Lijmer, JG; Sanson, BJ; Buller, HR; Brandjes, DPM
   Diagnostic accuracy of triage tests to exclude pulmonary embolism
   THROMBOSIS AND HAEMOSTASIS
   
   M.R. Mac Gillavry et al., "Diagnostic accuracy of triage tests to exclude pulmonary embolism", THROMB HAEM, 85(6), 2001, pp. 995-998
5. Hartmann, IJC; Prins, MH; Buller, HR; Banga, JD
   Acute pulmonary embolism: Impact of selection bias in prospective diagnostic studies
   THROMBOSIS AND HAEMOSTASIS
   
   I.J.C. Hartmann et al., "Acute pulmonary embolism: Impact of selection bias in prospective diagnostic studies", THROMB HAEM, 85(4), 2001, pp. 604-608
6. Kraaijenhagen, RA; Buller, HR
   Travel and risk of venous thrombosis - Reply
   LANCET
   
   R.A. Kraaijenhagen e H.R. Buller, "Travel and risk of venous thrombosis - Reply", LANCET, 357(9255), 2001, pp. 554-554
7. de Graaff, JC; Ubbink, DT; Buller, HR; Jacobs, MJHM
   The diagnosis of deep venous thrombosis using laser Doppler skin perfusionmeasurements
   MICROVASCULAR RESEARCH
   
   J.C. de Graaff et al., "The diagnosis of deep venous thrombosis using laser Doppler skin perfusionmeasurements", MICROVASC R, 61(1), 2001, pp. 49-55
8. van Ommen, CH; Heijboer, H; Buller, HR; Hirasing, RA; Heijmans, HSA; Peters, M
   Venous thromboembolism in childhood: A prospective two-year registry in The Netherlands
   JOURNAL OF PEDIATRICS
   
   C.H. van Ommen et al., "Venous thromboembolism in childhood: A prospective two-year registry in The Netherlands", J PEDIAT, 139(5), 2001, pp. 676-681
9. Friederich, PW; Levi, M; Bauer, KA; Vlasuk, GP; Rote, WE; Breederveld, D; Keller, T; Spataro, M; Barzegar, S; Buller, HR
   Ability of recombinant factor VIIa to generate thrombin during inhibition of tissue factor in human subjects
   CIRCULATION
   
   P.W. Friederich et al., "Ability of recombinant factor VIIa to generate thrombin during inhibition of tissue factor in human subjects", CIRCULATION, 103(21), 2001, pp. 2555-2559
10. Middeldorp, S; Libourel, EJ; Hamulyak, K; van der Meer, J; Buller, HR
    The risk of pregnancy-related venous thromboembolism in women who are homozygous for factor V Leiden
    BRITISH JOURNAL OF HAEMATOLOGY
    
    S. Middeldorp et al., "The risk of pregnancy-related venous thromboembolism in women who are homozygous for factor V Leiden", BR J HAEM, 113(2), 2001, pp. 553-555
11. Middeldorp, S; Meinardi, JR; Koopman, MMW; van Pampus, ECM; Hamulyak, K; van der Meer, J; Prins, MH; Buller, HR
    A prospective study of asymptomatic carriers of the factor V Leiden mutation to determine the incidence of venous thromboembolism
    ANNALS OF INTERNAL MEDICINE
    
    S. Middeldorp et al., "A prospective study of asymptomatic carriers of the factor V Leiden mutation to determine the incidence of venous thromboembolism", ANN INT MED, 135(5), 2001, pp. 322-327
12. Fisher, LD; Gent, M; Buller, HR
    Active-control trials: How would a new agent compare with placebo? A method illustrated clopidogrel, aspirin, and placebo
    AMERICAN HEART JOURNAL
    
    L.D. Fisher et al., "Active-control trials: How would a new agent compare with placebo? A method illustrated clopidogrel, aspirin, and placebo", AM HEART J, 141(1), 2001, pp. 26-32
13. Berghout, A; Oudkerk, M; Hicks, SG; Teng, TH; Pillay, M; Buller, HR
    Active implementation of a consensus strategy improves diagnosis and management in suspected pulmonary embolism
    QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS
    
    A. Berghout et al., "Active implementation of a consensus strategy improves diagnosis and management in suspected pulmonary embolism", QJM-MON J A, 93(6), 2000, pp. 335-340
14. Girolami, B; Bernardi, E; Prins, MH; ten Cate, JW; Prandoni, P; Simioni, P; Andreozzi, GM; Girolami, A; Buller, HR
    Antiplatelet therapy and other interventions after revascularisation procedures in patients with peripheral arterial disease: a meta-analysis
    EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY
    
    B. Girolami et al., "Antiplatelet therapy and other interventions after revascularisation procedures in patients with peripheral arterial disease: a meta-analysis", EUR J VAS E, 19(4), 2000, pp. 370-380
15. Bank, I; Middeldorp, S; Buller, HR
    Hereditary and acquired thrombophilia
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
    
    I. Bank et al., "Hereditary and acquired thrombophilia", SEM RESP CR, 21(6), 2000, pp. 483-491
16. Friederich, PW; Geerdink, MGF; Spataro, M; Messelink, EJ; Henny, CP; Buller, HR; Levi, M
    The effect of the administration of recombinant activated factor VII (NovoSeven (R)) on perioperative blood loss in patients undergoing transabdominal retropubic prostatectomy: the PROSE study
    BLOOD COAGULATION & FIBRINOLYSIS
    
    P.W. Friederich et al., "The effect of the administration of recombinant activated factor VII (NovoSeven (R)) on perioperative blood loss in patients undergoing transabdominal retropubic prostatectomy: the PROSE study", BL COAG FIB, 11, 2000, pp. S129-S132
17. Bijsterveld, NR; Middeldorp, S; Berends, F; Buller, HR
    Monitoring therapy with vitamin K antagonists in patients with lupus anticoagulant: Effect on different tests for INR determination
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    
    N.R. Bijsterveld et al., "Monitoring therapy with vitamin K antagonists in patients with lupus anticoagulant: Effect on different tests for INR determination", J THROMB TH, 9(3), 2000, pp. 263-269
18. Hutten, BA; Prins, MH; Gent, M; Ginsberg, J; Tijssen, JGP; Buller, HR
    Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved international normalized ratio: A retrospective analysis
    JOURNAL OF CLINICAL ONCOLOGY
    
    B.A. Hutten et al., "Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved international normalized ratio: A retrospective analysis", J CL ONCOL, 18(17), 2000, pp. 3078-3083
19. de Groot, MR; Oostdijk, AHJ; Engelage, AH; Kooy, MV; Buller, HR
    Changes in perfusion scintigraphy in the first days of heparin therapy in patients with acute pulmonary embolism
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    
    M.R. de Groot et al., "Changes in perfusion scintigraphy in the first days of heparin therapy in patients with acute pulmonary embolism", EUR J NUCL, 27(10), 2000, pp. 1481-1486
20. Mac Gillavry, MR; Sanson, BJ; Buller, HR; Brandjes, DPM
    Compression ultrasonography of the leg veins in patients with clinically suspected pulmonary embolism - Is a more extensive assessment of compressibility useful?
    THROMBOSIS AND HAEMOSTASIS
    
    M.R. Mac Gillavry et al., "Compression ultrasonography of the leg veins in patients with clinically suspected pulmonary embolism - Is a more extensive assessment of compressibility useful?", THROMB HAEM, 84(6), 2000, pp. 973-976
21. Middeldorp, S; Buller, HR
    How to decide on the optimal duration of anticoagulant therapy in carriersof the factor V Leiden mutation
    THROMBOSIS AND HAEMOSTASIS
    
    S. Middeldorp e H.R. Buller, "How to decide on the optimal duration of anticoagulant therapy in carriersof the factor V Leiden mutation", THROMB HAEM, 84(5), 2000, pp. 740-741
22. Friederich, PW; Keller, TT; Biemond, BJ; Peters, RJG; Hornberger, W; Buller, HR; Levi, M
    Successful attenuation of venous thrombus growth in rabbits after the administration of a novel oral thrombin inhibitor
    THROMBOSIS AND HAEMOSTASIS
    
    P.W. Friederich et al., "Successful attenuation of venous thrombus growth in rabbits after the administration of a novel oral thrombin inhibitor", THROMB HAEM, 84(5), 2000, pp. 858-864
23. Wallis, JW; Kruip, M; de Jongh-Leuvenink, J; Buller, HR
    A comparative study of two rapid D-dimer tests for the exclusion of pulmonary embolism in symptomatic patients
    THROMBOSIS AND HAEMOSTASIS
    
    J.W. Wallis et al., "A comparative study of two rapid D-dimer tests for the exclusion of pulmonary embolism in symptomatic patients", THROMB HAEM, 84(5), 2000, pp. 925-925
24. Mac Gillavry, MR; Sanson, BJ; de Monye, W; Lijmer, JG; Huisman, MV; Buller, HR; Nieuwenhuizen, W; Brandjes, DPM
    Use of a new monoclonal antibody-based enzyme immunoassay for soluble fibrin to exclude pulmonary embolism
    THROMBOSIS AND HAEMOSTASIS
    
    M.R. Mac Gillavry et al., "Use of a new monoclonal antibody-based enzyme immunoassay for soluble fibrin to exclude pulmonary embolism", THROMB HAEM, 84(3), 2000, pp. 474-477
25. Middeldorp, S; Meijers, JCM; van den Ende, AE; van Enk, A; Bouma, BN; Tans, G; Rosing, J; Prins, MH; Buller, HR
    Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral contraceptives: a cross-over study
    THROMBOSIS AND HAEMOSTASIS
    
    S. Middeldorp et al., "Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral contraceptives: a cross-over study", THROMB HAEM, 84(1), 2000, pp. 4-8
26. Meijers, JCM; Middeldorp, S; Tekelenburg, W; van den Ende, AE; Tans, G; Prins, MH; Rosing, J; Buller, HR; Bouma, BN
    Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis - A randomized cross-over study of two low-dose oral contraceptives
    THROMBOSIS AND HAEMOSTASIS
    
    J.C.M. Meijers et al., "Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis - A randomized cross-over study of two low-dose oral contraceptives", THROMB HAEM, 84(1), 2000, pp. 9-14
27. Tans, G; Curvers, J; Middeldorp, S; Thomassen, MCLGD; Meijers, JCM; Prins, MH; Bouma, BN; Buller, HR; Rosing, J
    A randomized cross-over study on the effects of levonorgestrel- and desogestrel-containing oral contraceptives on the anticoagulant pathways
    THROMBOSIS AND HAEMOSTASIS
    
    G. Tans et al., "A randomized cross-over study on the effects of levonorgestrel- and desogestrel-containing oral contraceptives on the anticoagulant pathways", THROMB HAEM, 84(1), 2000, pp. 15-21
28. Mac Gillavry, MR; de Monye, W; Lijmer, JG; Nieuwenhuizen, W; Buller, HR; Huisman, MV; Brandjes, DPM
    Clinical evaluation of a monoclonal antibody-based enzyme immunoassay for fibrin degradation products in patients with clinically suspected pulmonaryembolism
    THROMBOSIS AND HAEMOSTASIS
    
    M.R. Mac Gillavry et al., "Clinical evaluation of a monoclonal antibody-based enzyme immunoassay for fibrin degradation products in patients with clinically suspected pulmonaryembolism", THROMB HAEM, 83(6), 2000, pp. 892-895
29. Harenberg, J; Schmidt, JA; Koppenhagen, K; Tolle, A; Huisman, MV; Buller, HR
    Fixed-dose, body weight-independent subcutaneous LMW heparin versus adjusted dose unfractionated intravenous heparin in the initial treatment of proximal venous thrombosis
    THROMBOSIS AND HAEMOSTASIS
    
    J. Harenberg et al., "Fixed-dose, body weight-independent subcutaneous LMW heparin versus adjusted dose unfractionated intravenous heparin in the initial treatment of proximal venous thrombosis", THROMB HAEM, 83(5), 2000, pp. 652-656
30. de Groot, MR; Turkstra, F; Kooy, MV; Oostdijk, AHJ; van Beek, EJR; Buller, HR
    Value of chest X-ray combined with perfusion scan versus ventilation/perfusion scan in acute pulmonary embolism
    THROMBOSIS AND HAEMOSTASIS
    
    M.R. de Groot et al., "Value of chest X-ray combined with perfusion scan versus ventilation/perfusion scan in acute pulmonary embolism", THROMB HAEM, 83(3), 2000, pp. 412-415
31. Sanson, BJ; Lijmer, JG; Mac Gillavry, MR; Turkstra, F; Prins, MH; Buller, HR
    Comparison of a clinical probability estimate and two clinical models in patients with suspected pulmonary embolism
    THROMBOSIS AND HAEMOSTASIS
    
    B.J. Sanson et al., "Comparison of a clinical probability estimate and two clinical models in patients with suspected pulmonary embolism", THROMB HAEM, 83(2), 2000, pp. 199-203
32. Kraaijenhagen, RA; Anker, PSI; Koopman, MMW; Reitsma, PH; Prins, MH; van den Ende, A; Buller, HR
    High plasma concentration of factor ville is a major risk factor for venous thromboembolism
    THROMBOSIS AND HAEMOSTASIS
    
    R.A. Kraaijenhagen et al., "High plasma concentration of factor ville is a major risk factor for venous thromboembolism", THROMB HAEM, 83(1), 2000, pp. 5-9
33. van der Heijden, JF; Prins, MH; Buller, HR
    Low-molecular-weight heparins: Are they interchangeable?
    HAEMOSTASIS
    
    J.F. van der Heijden et al., "Low-molecular-weight heparins: Are they interchangeable?", HAEMOSTASIS, 30, 2000, pp. 148-157
34. van der Velde, EF; Kraaijenhagen, RA; van Weert, HCPM; Turkstra, F; Buller, HR
    Survey of the management of deep vein thrombosis in general practice in the Netherlands
    NETHERLANDS JOURNAL OF MEDICINE
    
    E.F. van der Velde et al., "Survey of the management of deep vein thrombosis in general practice in the Netherlands", NETH J MED, 57(4), 2000, pp. 135-141
35. Kraaijenhagen, RA; Haverkamp, D; Koopman, MNW; Prandoni, P; Piovella, F; Buller, HR
    Travel and risk of venous thrombosis
    LANCET
    
    R.A. Kraaijenhagen et al., "Travel and risk of venous thrombosis", LANCET, 356(9240), 2000, pp. 1492-1493
36. Cromheecke, ME; Levi, M; Colly, LP; de Mol, BJM; Prins, MH; Hutten, BA; Mak, R; Keyzers, KCJ; Buller, HR
    Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison
    LANCET
    
    M.E. Cromheecke et al., "Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison", LANCET, 356(9224), 2000, pp. 97-102
37. van der Heijden, JF; Prins, MH; Buller, HR
    For the initial treatment of venous thromboembolism: Are all low-molecular-weight heparin compounds the same?
    THROMBOSIS RESEARCH
    
    J.F. van der Heijden et al., "For the initial treatment of venous thromboembolism: Are all low-molecular-weight heparin compounds the same?", THROMB RES, 100(2), 2000, pp. V121-V130
38. van der Heijden, JF; Kraaijenhagen, RA; Buller, HR
    The risk of recurrent deep venous thrombosis
    NEW ENGLAND JOURNAL OF MEDICINE
    
    J.F. van der Heijden et al., "The risk of recurrent deep venous thrombosis", N ENG J MED, 342(3), 2000, pp. 214-215
39. Buller, HR; Cariou, R; Gallus, A; Gent, M; Ginsberg, J; Prins, MH; Lensing, A; Levi, M; Nurmohammed, N; Hirsh, J; Roberts, R; ten Cate, JW; Decousus, H; Mismetti, P; Buchmuller, A; Charlet, V; Viallon, A; van der Meer, J; Meinardi, JR; Meijer, K; Piovella, F; Barone, M; Beltrametti, C; Serafini, S; Kraaijenhagen, RA; Koopman, MMW; Jagt, HHT; Muller, MBR; Kooy, MV; Nauta, S; Gallus, AS; Coghlan, D; Rich, C; Prandoni, P; Scudeller, A; Scarano, L; Girolami, A; Baker, R; Tan, E; Cooney, J; Eikelboom, J; Ninet, J; Dolmazon, C; Madoux, MHG; Coppere, B; Nenci, GG; Agnelli, G; Falcinelli, F; Morini, M; d'Angelo, A; Crippa, L; d'Angelo, SV; Chong, B; Chestreman, C; Malvin, J; Eisbacher, M; MacGillavry, MR; Brandjes, DPM; Beaumont, JFM; Olmos, RAV; Turpie, AGG; Johnson, J; Nowacki, B; Anderson, D; Pleasance, S; Mitchell, M; Ockelford, P; Bennett, A; Jones, R; Porteous, F; Weitz, J; Kearon, C; Simonneau, G; Parent, F; Douketis, J; Schnurr, T; Hainaut, P; Petit, B; Jaumotte, C; Huisman, MV; van Poelgeest, MIE; Meinders, AE; van Oostayen, JA; Beer, J; Lugli, A; Pederiva, S; Ginsberg, J; Brill-Edwards, P; Stevens, P; Bassand, JP; Seronde, MF; Kassis, J; Fortin, M; Faivre, R; Petiteau, PY; Verhaeghe, R; Wells, P; Lewandowski, B; Touchie, D; Banga, JD; Hartmann, IJC; Zeguers, VJM; Desjardins, L; Villeneuve, J; Cote, J; Bounameaux, H; Cirafici, P; Demers, C; van der Heul, C; Kruip, M
    Treatment of proximal deep vein thrombosis with a novel synthetic compound(SR90107A/ORG31540) with pure anti-factor Xa activity - A phase II evaluation
    CIRCULATION
    
    H.R. Buller et al., "Treatment of proximal deep vein thrombosis with a novel synthetic compound(SR90107A/ORG31540) with pure anti-factor Xa activity - A phase II evaluation", CIRCULATION, 102(22), 2000, pp. 2726-2731
40. Ginsberg, JS; Gent, M; Turkstra, F; Buller, HR; MacKinnon, B; Magier, D; Hirsh, J
    Postthrombotic syndrome after hip or knee arthroplasty - A cross-sectionalstudy
    ARCHIVES OF INTERNAL MEDICINE
    
    J.S. Ginsberg et al., "Postthrombotic syndrome after hip or knee arthroplasty - A cross-sectionalstudy", ARCH IN MED, 160(5), 2000, pp. 669-672
41. Kruip, MJHA; Slob, MJ; Buller, HR; van der Heul, C
    A prospective clinical study on the feasibility and safety of a combined noninvasive/pulmonary angiography strategy in patients with suspected pulmonary embolism: An interim analysis
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
    
    M.J.H.A. Kruip et al., "A prospective clinical study on the feasibility and safety of a combined noninvasive/pulmonary angiography strategy in patients with suspected pulmonary embolism: An interim analysis", CL APPL T-H, 5(4), 1999, pp. 222-225
42. Moons, KGM; van Es, GA; Michel, BC; Buller, HR; Habbema, JDF; Grobbee, DE
    Redundancy of single diagnostic test evaluation
    EPIDEMIOLOGY
    
    K.G.M. Moons et al., "Redundancy of single diagnostic test evaluation", EPIDEMIOLOG, 10(3), 1999, pp. 276-281
43. de Groot, MR; Kooy, MV; Pouwels, JGJ; Engelage, AH; Kuipers, BF; Buller, HR
    The use at a rapid D-dimer blood test in the diagnostic work-up for pulmonary embolism: A management study
    THROMBOSIS AND HAEMOSTASIS
    
    M.R. de Groot et al., "The use at a rapid D-dimer blood test in the diagnostic work-up for pulmonary embolism: A management study", THROMB HAEM, 82(6), 1999, pp. 1588-1592
44. Smorenburg, SM; Hettiarachchi, RJK; Vink, R; Buller, HR
    The effects of unfractionated heparin on survival in patients with malignancy - A systematic review
    THROMBOSIS AND HAEMOSTASIS
    
    S.M. Smorenburg et al., "The effects of unfractionated heparin on survival in patients with malignancy - A systematic review", THROMB HAEM, 82(6), 1999, pp. 1600-1604
45. Hutten, BA; Prins, MH; Redekop, WK; Tijssen, JGP; Heisterkamp, SH; Buller, HR
    Comparison of three methods to assess therapeutic quality control of treatment with vitamin K antagonists
    THROMBOSIS AND HAEMOSTASIS
    
    B.A. Hutten et al., "Comparison of three methods to assess therapeutic quality control of treatment with vitamin K antagonists", THROMB HAEM, 82(4), 1999, pp. 1260-1263
46. Prins, MH; Hutten, BA; Koopman, MMW; Buller, HR
    Long-term treatment of venous thromboembolic disease
    THROMBOSIS AND HAEMOSTASIS
    
    M.H. Prins et al., "Long-term treatment of venous thromboembolic disease", THROMB HAEM, 82(2), 1999, pp. 892-898
47. Hettiarachchi, RJK; Smorenburg, SM; Ginsberg, J; Levine, M; Prins, MH; Buller, HR
    Do heparins do more than just treat thrombosis? The influence of heparins on cancer spread
    THROMBOSIS AND HAEMOSTASIS
    
    R.J.K. Hettiarachchi et al., "Do heparins do more than just treat thrombosis? The influence of heparins on cancer spread", THROMB HAEM, 82(2), 1999, pp. 947-952
48. van Pampus, MG; Koopman, MMW; Wolf, H; Buller, HR; Prins, MH; van den Ende, A
    Lipoprotein(a) concentrations in women with a history of severe preeclampsia - a case control study
    THROMBOSIS AND HAEMOSTASIS
    
    M.G. van Pampus et al., "Lipoprotein(a) concentrations in women with a history of severe preeclampsia - a case control study", THROMB HAEM, 82(1), 1999, pp. 10-13
49. Sanson, BJ; Lensing, AWA; Prins, MH; Ginsberg, JS; Barkagan, ZS; Lavenne-Pardonge, E; Brenner, B; Dulitzky, M; Nielsen, JD; Boda, Z; Turi, S; MacGillavry, MR; Hamulyak, K; Theunissen, IM; Hunt, BJ; Buller, HR
    Safety of low-molecular-weight heparin in pregnancy: A systematic review
    THROMBOSIS AND HAEMOSTASIS
    
    B.J. Sanson et al., "Safety of low-molecular-weight heparin in pregnancy: A systematic review", THROMB HAEM, 81(5), 1999, pp. 668-672
50. Girolami, B; Bernardi, E; Prins, MH; ten Cate, JW; Prandoni, P; Hettiarachchi, R; Marras, E; Stefani, PM; Girolami, A; Buller, HR
    Antithrombotic drugs in the primary medical management of intermittent claudication: A meta-analysis
    THROMBOSIS AND HAEMOSTASIS
    
    B. Girolami et al., "Antithrombotic drugs in the primary medical management of intermittent claudication: A meta-analysis", THROMB HAEM, 81(5), 1999, pp. 715-722
51. Turkstra, F; Karemaker, R; Kuijer, PMM; Prins, MH; Buller, HR
    Is the prevalence of the factor V Leiden mutation in patients with pulmonary embolism and deep vein thrombosis really different?
    THROMBOSIS AND HAEMOSTASIS
    
    F. Turkstra et al., "Is the prevalence of the factor V Leiden mutation in patients with pulmonary embolism and deep vein thrombosis really different?", THROMB HAEM, 81(3), 1999, pp. 345-348
52. Simioni, P; Sanson, BJ; Prandoni, P; Tormene, D; Friederich, PW; Girolami, B; Gavasso, S; Huisman, MV; Buller, HR; ten Cate, JW; Girolami, A; Prins, MH
    Incidence of venous thromboembolism in families with inherited thrombophilia
    THROMBOSIS AND HAEMOSTASIS
    
    P. Simioni et al., "Incidence of venous thromboembolism in families with inherited thrombophilia", THROMB HAEM, 81(2), 1999, pp. 198-202
53. Planes, A; Samama, MM; Lensing, AWA; Buller, HR; Barre, J; Vochelle, N; Beau, B
    Prevention of deep vein thrombosis after hip replacement - Comparison between two low-molecular-weight heparins, tinzaparin and enoxaparin
    THROMBOSIS AND HAEMOSTASIS
    
    A. Planes et al., "Prevention of deep vein thrombosis after hip replacement - Comparison between two low-molecular-weight heparins, tinzaparin and enoxaparin", THROMB HAEM, 81(1), 1999, pp. 22-25
54. Smorenburg, SM; Vink, R; te Lintelo, M; Tigchelaar, W; Maas, A; Buller, HR; van Noorden, CJF
    In vivo treatment of rats with unfractionated heparin (UFH) or low molecular weight heparin (LMWH) does not affect experimentally induced colon carcinoma metastasis
    CLINICAL & EXPERIMENTAL METASTASIS
    
    S.M. Smorenburg et al., "In vivo treatment of rats with unfractionated heparin (UFH) or low molecular weight heparin (LMWH) does not affect experimentally induced colon carcinoma metastasis", CLIN EXP M, 17(5), 1999, pp. 451-456
55. Rosing, J; Middeldorp, S; Curvers, J; Thomassen, MCLGD; Nicolaes, GAF; Meijers, JCM; Bouma, BN; Buller, HR; Prins, MH; Tans, G
    Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study
    LANCET
    
    J. Rosing et al., "Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study", LANCET, 354(9195), 1999, pp. 2036-2040
56. Levi, M; Cromheecke, ME; de Jonge, E; Prins, MH; de Mol, BJM; Briet, E; Buller, HR
    Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints
    LANCET
    
    M. Levi et al., "Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints", LANCET, 354(9194), 1999, pp. 1940-1947
57. Lensing, AWA; Prandoni, P; Prins, MH; Buller, HR
    Deep-vein thrombosis
    LANCET
    
    A.W.A. Lensing et al., "Deep-vein thrombosis", LANCET, 353(9151), 1999, pp. 479-485
58. Wittekoek, ME; de Groot, E; Prins, MH; Trip, MD; Buller, HR; Kastelein, JJP
    Differences in intima-media thickness in the carotid and femoral arteries in familial hypercholesterolemic heterozygotes with and without clinical manifestations of cardiovascular disease
    ATHEROSCLEROSIS
    
    M.E. Wittekoek et al., "Differences in intima-media thickness in the carotid and femoral arteries in familial hypercholesterolemic heterozygotes with and without clinical manifestations of cardiovascular disease", ATHEROSCLER, 146(2), 1999, pp. 271-279
59. Levi, M; Middeldorp, S; Buller, HR
    Oral contraceptives and hormonal replacement therapy cause an imbalance incoagulation and fibrinolysis which may explain the increased risk of venous thromboembolism
    CARDIOVASCULAR RESEARCH
    
    M. Levi et al., "Oral contraceptives and hormonal replacement therapy cause an imbalance incoagulation and fibrinolysis which may explain the increased risk of venous thromboembolism", CARDIO RES, 41(1), 1999, pp. 21-24
60. Meinardi, JR; Pelsma, PM; Koning, H; van der Meer, J; Middeldorp, S; Buller, HR; Hamulyak, K
    Double-homozygosity for factor V Leiden and the prothrombin gene G20210A variant in a young patient with idiopathic venous thrombosis
    BLOOD
    
    J.R. Meinardi et al., "Double-homozygosity for factor V Leiden and the prothrombin gene G20210A variant in a young patient with idiopathic venous thrombosis", BLOOD, 94(5), 1999, pp. 1828-1829
61. Sanson, BJ; Simioni, P; Tormene, D; Moia, M; Friederich, PW; Huisman, MV; Prandoni, P; Bura, A; Rejto, L; Wells, P; Mannucci, PM; Girolami, A; Buller, HR; Prins, MH
    The incidence of venous thromboembolism in asymptomatic carriers of a deficiency of antithrombin, protein C, or protein S: A prospective cohort study
    BLOOD
    
    B.J. Sanson et al., "The incidence of venous thromboembolism in asymptomatic carriers of a deficiency of antithrombin, protein C, or protein S: A prospective cohort study", BLOOD, 94(11), 1999, pp. 3702-3706
62. Kuijer, PMM; Hutten, BA; Prins, MH; Buller, HR
    Prediction of the risk of bleeding during anticoagulant treatment for venous thromboembolism
    ARCHIVES OF INTERNAL MEDICINE
    
    P.M.M. Kuijer et al., "Prediction of the risk of bleeding during anticoagulant treatment for venous thromboembolism", ARCH IN MED, 159(5), 1999, pp. 457-460
63. Girolami, B; Bernardi, E; Prins, MH; ten Cate, JW; Hettiarachchi, R; Prandoni, P; Girolami, A; Buller, HR
    Treatment of intermittent claudication with physical training, smoking cessation, pentoxifylline, or nafronyl - A meta-analysis
    ARCHIVES OF INTERNAL MEDICINE
    
    B. Girolami et al., "Treatment of intermittent claudication with physical training, smoking cessation, pentoxifylline, or nafronyl - A meta-analysis", ARCH IN MED, 159(4), 1999, pp. 337-345
64. Bloemenkamp, KWM; Rosendaal, FP; Buller, HR; Helmerhorst, FM; Colly, LP; Vandenbroucke, JP
    Risk of venous thrombosis with use of current low-dose oral contraceptivesis not explained by diagnostic suspicion and referral bias
    ARCHIVES OF INTERNAL MEDICINE
    
    K.W.M. Bloemenkamp et al., "Risk of venous thrombosis with use of current low-dose oral contraceptivesis not explained by diagnostic suspicion and referral bias", ARCH IN MED, 159(1), 1999, pp. 65-70
65. Meinardi, JR; Middeldorp, S; de Kam, PJ; Koopman, MMW; van Pampus, ECM; Hamulyak, K; Prins, MH; Buller, HR; van der Meer, J
    Increased risk for fetal loss in carriers of the factor V Leiden mutation
    ANNALS OF INTERNAL MEDICINE
    
    J.R. Meinardi et al., "Increased risk for fetal loss in carriers of the factor V Leiden mutation", ANN INT MED, 130(9), 1999, pp. 736-739
66. Koopman, MMW; Buller, HR
    Low-molecular-weight heparin for treating venous thromboembolism - Response
    ANNALS OF INTERNAL MEDICINE
    
    M.M.W. Koopman e H.R. Buller, "Low-molecular-weight heparin for treating venous thromboembolism - Response", ANN INT MED, 130(1), 1999, pp. 77-78
67. van Pampus, MG; Dekker, GA; Wolf, H; Huijgens, PC; Koopman, MMW; von Blomberg, BME; Buller, HR
    High prevalence of hemostatic abnormalities in women with a history of severe preeclampsia
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
    
    M.G. van Pampus et al., "High prevalence of hemostatic abnormalities in women with a history of severe preeclampsia", AM J OBST G, 180(5), 1999, pp. 1146-1150
68. CHAMULEAU SAJ; DEWINTER RJ; LEVI M; ADAMS R; BULLER HR; PRINS MH; LIE KI; PETERS RJG
    LOW-MOLECULAR-WEIGHT HEPARIN AS AN ADJUNCT TO THROMBOLYSIS FOR ACUTE MYOCARDIAL-INFARCTION - THE FATIMA STUDY
    HEART
    
    S.A.J. Chamuleau et al., "LOW-MOLECULAR-WEIGHT HEPARIN AS AN ADJUNCT TO THROMBOLYSIS FOR ACUTE MYOCARDIAL-INFARCTION - THE FATIMA STUDY", HEART, 80(1), 1998, pp. 35-39
69. DEGRAAFF JC; UBBINK DT; LANGENHUIJSEN JF; BULLER HR; JACOBS MJHM
    DISTURBED PERIPHERAL VASOCONSTRICTION RESPONSE IN LEGS WITH DEEP VENOUS THROMBOSIS AS DETECTED BY LASER-DOPPLER FLUXMETRY
    Journal of vascular research
    
    J.C. Degraaff et al., "DISTURBED PERIPHERAL VASOCONSTRICTION RESPONSE IN LEGS WITH DEEP VENOUS THROMBOSIS AS DETECTED BY LASER-DOPPLER FLUXMETRY", Journal of vascular research, 35, 1998, pp. 275-275
70. COGO A; LENSING AWA; KOOPMAN MMW; PIOVELLA F; SIRAGUSA S; WELLS PS; VILLALTA S; BULLER HR; TURPIE AGG; PRANDONI P
    COMPRESSION ULTRASONOGRAPHY FOR DIAGNOSTIC MANAGEMENT OF PATIENTS WITH CLINICALLY SUSPECTED DEEP-VEIN THROMBOSIS - PROSPECTIVE COHORT STUDY
    BMJ. British medical journal
    
    A. Cogo et al., "COMPRESSION ULTRASONOGRAPHY FOR DIAGNOSTIC MANAGEMENT OF PATIENTS WITH CLINICALLY SUSPECTED DEEP-VEIN THROMBOSIS - PROSPECTIVE COHORT STUDY", BMJ. British medical journal, 316(7124), 1998, pp. 17-20
71. Kraaijenhagen, RA; Lensing, AWA; Wallis, JW; van Beek, EJR; ten Cate, JW; Buller, HR
    Diagnostic management of venous thromboembolism
    BAILLIERES CLINICAL HAEMATOLOGY
    
    R.A. Kraaijenhagen et al., "Diagnostic management of venous thromboembolism", BAIL CLIN H, 11(3), 1998, pp. 541-586
72. DEGROOT MR; BULLER HR; TENCATE JW; KOOY MV
    USE OF A HEPARIN NOMOGRAM FOR TREATMENT OF PATIENTS WITH VENOUS THROMBOEMBOLISM IN A COMMUNITY-HOSPITAL
    Thrombosis and haemostasis
    
    M.R. Degroot et al., "USE OF A HEPARIN NOMOGRAM FOR TREATMENT OF PATIENTS WITH VENOUS THROMBOEMBOLISM IN A COMMUNITY-HOSPITAL", Thrombosis and haemostasis, 80(1), 1998, pp. 70-73
73. VANDENBELT AGM; BOSSUYT PMM; PRINS MH; GALLUS AS; BULLER HR
    REPLACING INPATIENT CARE BY OUTPATIENT CARE IN THE TREATMENT OF DEEP VENOUS THROMBOSIS - AN ECONOMIC-EVALUATION
    Thrombosis and haemostasis
    
    A.G.M. Vandenbelt et al., "REPLACING INPATIENT CARE BY OUTPATIENT CARE IN THE TREATMENT OF DEEP VENOUS THROMBOSIS - AN ECONOMIC-EVALUATION", Thrombosis and haemostasis, 79(2), 1998, pp. 259-263
74. TURKSTRA F; VANBEEK EJR; BULLER HR
    OBSERVER AND BIOLOGICAL VARIATION OF A RAPID WHOLE-BLOOD D-DIMER TEST
    Thrombosis and haemostasis
    
    F. Turkstra et al., "OBSERVER AND BIOLOGICAL VARIATION OF A RAPID WHOLE-BLOOD D-DIMER TEST", Thrombosis and haemostasis, 79(1), 1998, pp. 91-93
75. Buller, HR
    Outpatient therapy with low-molecular-weight heparins: New perspectives for treatment of deep vein thrombosis
    HAEMOSTASIS
    
    H.R. Buller, "Outpatient therapy with low-molecular-weight heparins: New perspectives for treatment of deep vein thrombosis", HAEMOSTASIS, 28, 1998, pp. 91-94
76. VANPAMPUS MG; KOOPMAN MMW; WOLF H; BULLER HR; PRINS MH
    LIPOPROTEIN(A) CONCENTRATIONS IN PATIENTS WITH A HISTORY OF SEVERE PREECLAMPSIA - A CASE-CONTROL STUDY
    Clinical chemistry
    
    M.G. Vanpampus et al., "LIPOPROTEIN(A) CONCENTRATIONS IN PATIENTS WITH A HISTORY OF SEVERE PREECLAMPSIA - A CASE-CONTROL STUDY", Clinical chemistry, 44, 1998, pp. 360-360
77. LEVI M; PETERS RJG; BULLER HR
    WEIGHT WATCHING IN CARDIOLOGY - LOW-MOLECULAR-WEIGHT HEPARIN FOR ACUTE CORONARY SYNDROMES
    Cardiovascular Research
    
    M. Levi et al., "WEIGHT WATCHING IN CARDIOLOGY - LOW-MOLECULAR-WEIGHT HEPARIN FOR ACUTE CORONARY SYNDROMES", Cardiovascular Research, 37(3), 1998, pp. 564-566
78. HETTIARACHCHI RJK; LOK J; PRINS MH; BULLER HR; PRANDONI P
    UNDIAGNOSED MALIGNANCY IN PATIENTS WITH DEEP-VEIN THROMBOSIS - INCIDENCE, RISK INDICATORS, AND DIAGNOSIS
    Cancer
    
    R.J.K. Hettiarachchi et al., "UNDIAGNOSED MALIGNANCY IN PATIENTS WITH DEEP-VEIN THROMBOSIS - INCIDENCE, RISK INDICATORS, AND DIAGNOSIS", Cancer, 83(1), 1998, pp. 180-185
79. DEGROOT MR; BULLER HR; TENCATE JW; ENGELAGE AH; POUWELS J; KUIPERS AF; BOM EP; KOOY MV
    USE OF A RAPID BLOOD-TEST IN THE WORK-UP FOR PULMONARY-EMBOLISM - PRELIMINARY-RESULTS OF A MANAGEMENT STUDY
    British Journal of Haematology
    
    M.R. Degroot et al., "USE OF A RAPID BLOOD-TEST IN THE WORK-UP FOR PULMONARY-EMBOLISM - PRELIMINARY-RESULTS OF A MANAGEMENT STUDY", British Journal of Haematology, 102(1), 1998, pp. 262-262
80. TURKSTRA F; VANBEEK EJR; BULLER HR
    ULTRASONOGRAPHY OF LEG VEINS IN PATIENTS SUSPECTED OF HAVING PULMONARY-EMBOLISM - RESPONSE
    Annals of internal medicine
    
    F. Turkstra et al., "ULTRASONOGRAPHY OF LEG VEINS IN PATIENTS SUSPECTED OF HAVING PULMONARY-EMBOLISM - RESPONSE", Annals of internal medicine, 128(3), 1998, pp. 244-245
81. KOOPMAN MMW; BULLER HR
    LOW-MOLECULAR-WEIGHT HEPARINS IN THE TREATMENT OF VENOUS THROMBOEMBOLISM
    Annals of internal medicine
    
    M.M.W. Koopman e H.R. Buller, "LOW-MOLECULAR-WEIGHT HEPARINS IN THE TREATMENT OF VENOUS THROMBOEMBOLISM", Annals of internal medicine, 128(12), 1998, pp. 1037-1039
82. MIDDELDORP S; HENKENS CMA; KOOPMAN MMW; VANPAMPUS ECM; HAMULYAK K; VANDERMEER J; PRINS MH; BULLER HR
    THE INCIDENCE OF VENOUS THROMBOEMBOLISM IN FAMILY MEMBERS OF PATIENTSWITH FACTOR-V-LEIDEN MUTATION AND VENOUS THROMBOSIS
    Annals of internal medicine
    
    S. Middeldorp et al., "THE INCIDENCE OF VENOUS THROMBOEMBOLISM IN FAMILY MEMBERS OF PATIENTSWITH FACTOR-V-LEIDEN MUTATION AND VENOUS THROMBOSIS", Annals of internal medicine, 128(1), 1998, pp. 15
83. GRAAFSMA YP; PRINS MH; LENSING AWA; DEHAAN RJ; HUISMAN MV; BULLER HR
    BLEEDING CLASSIFICATION IN CLINICAL-TRIALS - OBSERVER VARIABILITY ANDCLINICAL RELEVANCE
    Thrombosis and haemostasis
    
    Y.P. Graafsma et al., "BLEEDING CLASSIFICATION IN CLINICAL-TRIALS - OBSERVER VARIABILITY ANDCLINICAL RELEVANCE", Thrombosis and haemostasis, 78(4), 1997, pp. 1189-1192
84. MICHEL BC; KUIJER PMM; MCDONNELL J; VANBEEK EJR; RUTTEN FFH; BULLER HR
    THE ROLE OF A DECISION RULE IN SYMPTOMATIC PULMONARY-EMBOLISM PATIENTS WITH A NON-HIGH PROBABILITY VENTILATION-PERFUSION SCAN
    Thrombosis and haemostasis
    
    B.C. Michel et al., "THE ROLE OF A DECISION RULE IN SYMPTOMATIC PULMONARY-EMBOLISM PATIENTS WITH A NON-HIGH PROBABILITY VENTILATION-PERFUSION SCAN", Thrombosis and haemostasis, 78(2), 1997, pp. 794-798
85. TURKSTRA F; KOOPMAN MMW; BULLER HR
    THE TREATMENT OF DEEP-VEIN THROMBOSIS AND PULMONARY-EMBOLISM
    Thrombosis and haemostasis
    
    F. Turkstra et al., "THE TREATMENT OF DEEP-VEIN THROMBOSIS AND PULMONARY-EMBOLISM", Thrombosis and haemostasis, 78(1), 1997, pp. 489-496
86. TURKSTRA F; VANBEEK EJR; TENCATE JW; BULLER HR
    RAPID BLOOD-TEST FOR THE EXCLUSION OF VENOUS THROMBOEMBOLISM IN SYMPTOMATIC OUTPATIENTS - REBUTTAL
    Thrombosis and haemostasis
    
    F. Turkstra et al., "RAPID BLOOD-TEST FOR THE EXCLUSION OF VENOUS THROMBOEMBOLISM IN SYMPTOMATIC OUTPATIENTS - REBUTTAL", Thrombosis and haemostasis, 77(5), 1997, pp. 1043-1043
87. KRAAIJENHAGEN RA; KOOPMAN MMW; BERNARDI E; VERLATO F; PIOVELLA F; SIRAGUSA S; BULLER HR
    SIMPLIFICATION OF THE DIAGNOSTIC MANAGEMENT OF OUTPATIENTS WITH SYMPTOMATIC DEEP-VEIN THROMBOSIS WITH D-DIMER MEASUREMENTS
    Thrombosis and haemostasis
    
    R.A. Kraaijenhagen et al., "SIMPLIFICATION OF THE DIAGNOSTIC MANAGEMENT OF OUTPATIENTS WITH SYMPTOMATIC DEEP-VEIN THROMBOSIS WITH D-DIMER MEASUREMENTS", Thrombosis and haemostasis, 1997, pp. 652-652
88. MOONS KGM; MICHEL BC; BULLER HR; HABBEMA JDF; GROBBEE DE
    EVALUATION OF THE INDEPENDENT DIAGNOSTIC DETERMINANTS OF PULMONARY-EMBOLISM AMONG PATIENT HISTORY, PHYSICAL-EXAMINATION, BLOOD-GAS ANALYSIS, CHEST-X-RAY AND PERFUSION LUNG SCINTIGRAPHY
    Thrombosis and haemostasis
    
    K.G.M. Moons et al., "EVALUATION OF THE INDEPENDENT DIAGNOSTIC DETERMINANTS OF PULMONARY-EMBOLISM AMONG PATIENT HISTORY, PHYSICAL-EXAMINATION, BLOOD-GAS ANALYSIS, CHEST-X-RAY AND PERFUSION LUNG SCINTIGRAPHY", Thrombosis and haemostasis, 1997, pp. 744-744
89. DEGROOT MR; BULLER HR; TENCATE JW; KOOY MV
    APPLICATION OF A WEIGHT-BASED HEPARIN NOMOGRAM IN A COMMUNITY-HOSPITAL
    Thrombosis and haemostasis
    
    M.R. Degroot et al., "APPLICATION OF A WEIGHT-BASED HEPARIN NOMOGRAM IN A COMMUNITY-HOSPITAL", Thrombosis and haemostasis, 1997, pp. 1143-1143
90. DEWINTER RJ; LEVI M; CHAMULEAU SAJ; ADAMS R; BULLER HR; PRINS M; PETERS RJG
    ANTI-XA LEVELS WITH LOW-MOLECULAR-WEIGHT HEPARIN (FRAXIPARIN) AND THROMBOLYTIC THERAPY FOR ACUTE MYOCARDIAL-INFARCTION
    Thrombosis and haemostasis
    
    R.J. Dewinter et al., "ANTI-XA LEVELS WITH LOW-MOLECULAR-WEIGHT HEPARIN (FRAXIPARIN) AND THROMBOLYTIC THERAPY FOR ACUTE MYOCARDIAL-INFARCTION", Thrombosis and haemostasis, 1997, pp. 1168-1168
91. GRAAFSMA YP; PRINS MH; LENSING AWA; HUISMAR MV; BULLER HR
    BLEEDING CLASSIFICATION IN CLINICAL-TRIALS - OBSERVER VARIABILITY ANDCLINICAL RELEVANCE
    Thrombosis and haemostasis
    
    Y.P. Graafsma et al., "BLEEDING CLASSIFICATION IN CLINICAL-TRIALS - OBSERVER VARIABILITY ANDCLINICAL RELEVANCE", Thrombosis and haemostasis, 1997, pp. 1181-1181
92. HETTIARACHCHI RJK; PRINS MH; BULLER HR; PRANDONI P; TENCATE JW
    OCCULT MALIGNANCY IN PATIENTS WITH DEEP-VEIN THROMBOSIS - INCIDENCE AND RISK INDICATORS
    Thrombosis and haemostasis
    
    R.J.K. Hettiarachchi et al., "OCCULT MALIGNANCY IN PATIENTS WITH DEEP-VEIN THROMBOSIS - INCIDENCE AND RISK INDICATORS", Thrombosis and haemostasis, 1997, pp. 1563-1563
93. MIDDELDORP S; HENKENS CMA; KOOPMAN MMW; VANPAMPUS ECM; HAMULYAK K; VANDERMEER J; PRINS MH; BULLER HR
    DOES THE RISK OF VENOUS THROMBOEMBOLISM (VTE) IN FIRST DEGREE FAMILY MEMBERS OF PATIENTS WITH VTE AND THE FV-Q(506) MUTATION JUSTIFY FAMILYSCREENING
    Thrombosis and haemostasis
    
    S. Middeldorp et al., "DOES THE RISK OF VENOUS THROMBOEMBOLISM (VTE) IN FIRST DEGREE FAMILY MEMBERS OF PATIENTS WITH VTE AND THE FV-Q(506) MUTATION JUSTIFY FAMILYSCREENING", Thrombosis and haemostasis, 1997, pp. 2370-2370
94. VANAKEN BE; JANSEN J; REITSMA PH; BULLER HR; VANDEVENTER SJH
    IL-6 PRODUCTION IS INCREASED BY HOMOCYSTEINE IN HUMAN MONOCYTIC CELL-LINE MONO-MAC-6
    Thrombosis and haemostasis
    
    B.E. Vanaken et al., "IL-6 PRODUCTION IS INCREASED BY HOMOCYSTEINE IN HUMAN MONOCYTIC CELL-LINE MONO-MAC-6", Thrombosis and haemostasis, 1997, pp. 2373-2373
95. HUTTEN BA; PRINS MH; TIJSSEN JGP; BULLER HR
    THE INCIDENCE OF RECURRENT THROMBOEMBOLIC AND BLEEDING COMPLICATIONS AMONG PATIENTS WITH VENOUS THROMBOEMBOLISM IN RELATION TO MALIGNANCY AND ACHIEVED INR
    Thrombosis and haemostasis
    
    B.A. Hutten et al., "THE INCIDENCE OF RECURRENT THROMBOEMBOLIC AND BLEEDING COMPLICATIONS AMONG PATIENTS WITH VENOUS THROMBOEMBOLISM IN RELATION TO MALIGNANCY AND ACHIEVED INR", Thrombosis and haemostasis, 1997, pp. 2398-2398
96. DEGROOT MR; OOSTDIJK AHJ; BULLER HR; TENCATE JW; KOOY MV
    VALUE OF VENTILATION PERFUSION SCAN VERSUS PERFUSION SCAN CHEST-X-RAYIN ACUTE PULMONARY-EMBOLISM/
    Thrombosis and haemostasis
    
    M.R. Degroot et al., "VALUE OF VENTILATION PERFUSION SCAN VERSUS PERFUSION SCAN CHEST-X-RAYIN ACUTE PULMONARY-EMBOLISM/", Thrombosis and haemostasis, 1997, pp. 2890-2890
97. TURKSTRA F; KUIJER PMM; KAREMAKER R; VANBEEK EJR; TENCATE JW; BULLER HR
    VALIDATION OF A CLINICAL DECISION RULE IN PATIENTS WITH SUSPECTED PULMONARY-EMBOLISM AND A NONDIAGNOSTIC LUNG-SCAN
    Thrombosis and haemostasis
    
    F. Turkstra et al., "VALIDATION OF A CLINICAL DECISION RULE IN PATIENTS WITH SUSPECTED PULMONARY-EMBOLISM AND A NONDIAGNOSTIC LUNG-SCAN", Thrombosis and haemostasis, 1997, pp. 2891-2891
98. MOONS KGM; VANES GA; MICHEL BC; BULLER HR; HABBEMA JDF; GROBBEE DE
    HAZARDS OF AN UNIVARIATE APPROACH IN THE COMPARISON OF 3 TESTS TO DIAGNOSE PULMONARY-EMBOLISM
    Thrombosis and haemostasis
    
    K.G.M. Moons et al., "HAZARDS OF AN UNIVARIATE APPROACH IN THE COMPARISON OF 3 TESTS TO DIAGNOSE PULMONARY-EMBOLISM", Thrombosis and haemostasis, 1997, pp. 2898-2898
99. BLOEMENKAMP KWM; ROSENDAAL FR; BULLER HR; HELMERHORST FM; COLLY LP; VANDENBROUCKE JP
    THE ASSOCIATION BETWEEN ORAL-CONTRACEPTIVES AND VENOUS THROMBOSIS IS NOT EXPLAINED BY DIAGNOSTIC SUSPICION AND REFERRAL BIAS
    Thrombosis and haemostasis
    
    K.W.M. Bloemenkamp et al., "THE ASSOCIATION BETWEEN ORAL-CONTRACEPTIVES AND VENOUS THROMBOSIS IS NOT EXPLAINED BY DIAGNOSTIC SUSPICION AND REFERRAL BIAS", Thrombosis and haemostasis, 1997, pp. 2903-2903
100. KUIJER PMM; GALLUS AS; CHESTERMAN CN; PRINS MH; BULLER HR
     HEMOSTATIC RISK-FACTORS AND THE RISK OF RECURRENCE IN PATIENTS WITH VENOUS THROMBOEMBOLISM
     Thrombosis and haemostasis
     
     P.M.M. Kuijer et al., "HEMOSTATIC RISK-FACTORS AND THE RISK OF RECURRENCE IN PATIENTS WITH VENOUS THROMBOEMBOLISM", Thrombosis and haemostasis, 1997, pp. 2920-2920